RT Journal Article
T1 Simple dialkyl pyrazole-3,5-dicarboxylates show in vitro and in vivo activity against disease-causing trypanosomatids.
A1 Reviriego, Felipe
A1 Olmo, Francisco
A1 Navarro, Pilar
A1 Marin, Clotilde
A1 Ramirez-Macias, Inmaculada
A1 Garcia-España, Enrique
A1 Albelda, Maria Teresa
A1 Gutirrrez-Sanchez, Ramon
A1 Sanchez-Moreno, Manuel
A1 Aran, Vicente J
K1 Leishmania
K1 Trypanosoma
K1 antichagasic activity
K1 cytotoxicity
K1 leishmanicidal activity
K1 pyrazole
AB The synthesis and antiprotozoal activity of some simple dialkyl pyrazole-3,5-dicarboxylates (compounds 2-6) and their sodium salts (pyrazolates) (compounds 7-9) against Trypanosoma cruzi, Leishmania infantum and Leishmania braziliensis are reported. In most cases the studied compounds showed, especially against the clinically significant amastigote forms, in vitro activities higher than those of the reference drugs (benznidazole for T. cruzi and glucantime for Leishmania spp.); furthermore, the low non-specific cytotoxicities against Vero cells and macrophages shown by these compounds led to good selectivity indexes, which are 8-72 times higher for T. cruzi amastigotes and 15-113 times higher for Leishmania spp. amastigotes than those of the respective reference drugs. The high efficiency of diethyl ester 3 and its sodium salt 8 against the mentioned protozoa was confirmed by further in vitro assays on infection rates and by an additional in vivo study in a murine model of acute and chronic Chagas disease. The inhibitory capacity of compounds 3 and 8 on the essential iron superoxide dismutase of the aforementioned parasites may be related to the observed anti-trypanosomatid activity. The low acute toxicity of compounds 3 and 8 in mice is also reported in this article.
PB Cambridge University Press
YR 2017
FD 2017-04-03
LK http://hdl.handle.net/10668/11038
UL http://hdl.handle.net/10668/11038
LA en
NO Reviriego F, Olmo F, Navarro P, Marín C, Ramírez-Macías I, García-España E, et al. Simple dialkyl pyrazole-3,5-dicarboxylates show in vitro and in vivo activity against disease-causing trypanosomatids. Parasitology. 2017 Aug;144(9):1133-1143.
DS RISalud
RD Apr 16, 2025